πŸ‡ΊπŸ‡Έ FDA
Patent

US 12065416

cGAS antagonist compounds

granted A61KA61K31/381A61K31/426

Quick answer

US patent 12065416 (cGAS antagonist compounds) held by The Board of Regents of the University of Texas System expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K31/381, A61K31/426, A61K31/427, A61K31/429